Physician
Bolivar Physician Practices LLC
Bolivar Physician Practices LLC was paid $3.05M by Medicaid between Jan 2018 and Dec 2024, across 103 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.
33Billing provider infoBOLIVAR PHYSICIAN PRACTICES LLC
CLEVELAND, MS 38732
CLEVELAND, MS 38732
33aNPI1043454655assigned 04/27/2009
33bProvider typeInternal Medicine Physician
28Total paid$3.05M
24GClaims247,427
24DCodes billed103
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Mississippi
Rank by total paid#7 of 139
Median peer was paid$26K
This provider vs. median117×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TEAGUE, KATHY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,118 | $661K | |
| 2019 | 28,905 | $585K | |
| 2020 | 19,589 | $400K | |
| 2021 | 36,681 | $455K | |
| 2022 | 49,705 | $401K | |
| 2023 | 42,537 | $311K | |
| 2024incomplete | 35,892 | $239K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 33,362 | 27,511 | $1.26M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 27,611 | 21,519 | $752K |
| 99223 | Prolong inpt eval add15 m | 6.9% | 3,254 | 2,920 | $209K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.7% | 3,702 | 2,534 | $142K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.8% | 3,552 | 2,070 | $85K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.1% | 1,466 | 1,035 | $63K |
| 99238 | Hospital discharge day management, 30 minutes or less | 2.0% | 3,443 | 3,153 | $62K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 1.9% | 4,293 | 3,694 | $59K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 12,116 | 9,291 | $54K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.2% | 749 | 671 | $37K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 1,912 | 1,632 | $27K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,664 | 9,751 | $25K |
91 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,301 | $21K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,090 | $20K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 589 | $17K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,039 | $14K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 179 | $14K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,791 | $14K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,641 | $14K |
| 80061 | Lipid panel | <1% | 3,781 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,673 | $13K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 222 | $10K |
| 87428 | <1% | 898 | $10K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 592 | $9K |
| 80053 | Comprehensive metabolic panel | <1% | 3,624 | $9K |
| 54161 | <1% | 66 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 378 | $6K |
| 80047 | <1% | 2,586 | $6K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 279 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 892 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,497 | $5K |
| 82607 | <1% | 1,423 | $5K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,729 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 437 | $4K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 313 | $4K |
| 99318 | <1% | 176 | $3K | |
| 11043 | <1% | 56 | $3K | |
| 83880 | <1% | 584 | $3K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 1,101 | $3K |
| 81001 | <1% | 2,455 | $2K | |
| 99307 | <1% | 257 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 503 | $2K |
| 99305 | <1% | 42 | $2K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 13 | $2K |
| 82044 | <1% | 854 | $2K | |
| 90686 | <1% | 324 | $2K | |
| 90674 | <1% | 117 | $1K | |
| 80050 | General health panel | <1% | 43 | $1K |
| 81003 | <1% | 2,987 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,730 | $1K |
| J2010 | Injection, lincomycin hcl, up to 300 mg | <1% | 374 | $923.44 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 69 | $885.74 |
| 81000 | <1% | 489 | $858.65 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,264 | $853.05 |
| 80076 | <1% | 542 | $788.10 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 51 | $781.54 |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 30 | $724.25 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,084 | $684.18 |
| 82947 | <1% | 435 | $595.72 | |
| 80305 | <1% | 317 | $508.24 | |
| 81025 | <1% | 65 | $424.30 | |
| 90756 | <1% | 314 | $418.82 | |
| 73564 | <1% | 26 | $416.91 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 32 | $391.21 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 32 | $297.95 |
| 73610 | <1% | 15 | $282.45 | |
| 93000 | <1% | 100 | $264.88 | |
| 99497 | <1% | 424 | $257.18 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 140 | $240.53 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 16 | $220.97 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 142 | $144.18 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 286 | $125.05 |
| 87807 | <1% | 15 | $115.23 | |
| 82728 | <1% | 54 | $110.43 | |
| 84481 | <1% | 49 | $105.23 | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 13 | $100.10 |
| 97597 | <1% | 16 | $94.77 | |
| G0008 | Administration of influenza virus vaccine | <1% | 811 | $91.75 |
| 83550 | <1% | 52 | $70.83 | |
| 82040 | <1% | 33 | $53.52 | |
| 83540 | <1% | 52 | $52.38 | |
| 83735 | <1% | 76 | $41.61 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 89 | $34.84 |
| 85379 | <1% | 15 | $33.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 47 | $32.65 |
| 99000 | <1% | 178 | $12.00 | |
| 3079F | 0% | 3,497 | $0.00 | |
| 1036F | 0% | 19,592 | $0.00 | |
| 1125F | 0% | 550 | $0.00 | |
| 3074F | 0% | 8,761 | $0.00 | |
| 3008F | 0% | 14,117 | $0.00 | |
| 3080F | 0% | 1,083 | $0.00 | |
| 1126F | 0% | 614 | $0.00 | |
| 3075F | 0% | 1,992 | $0.00 | |
| 1034F | 0% | 1,338 | $0.00 | |
| 1035F | 0% | 165 | $0.00 | |
| 99496 | 0% | 35 | $0.00 | |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 0% | 33 | $0.00 |
| 1160F | 0% | 17,666 | $0.00 | |
| 3078F | 0% | 10,487 | $0.00 | |
| 3077F | 0% | 4,291 | $0.00 | |
| 3725F | 0% | 61 | $0.00 | |
| 90653 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTEAGUE, KATHY (VP, CORPORATE SECRETARY)
Parent organizationKNIGHT HEALTH HOLDINGS LLC
| Provider | Location | Paid |
|---|---|---|
| Rchp-Wilmington, LLC | Wilmington, OH | $13.53M |
| Providence Hospital, LLC | Columbia, SC | $12.68M |
| Vaughan Regional Medical Center LLC | Selma, AL | $8.15M |
| Kershaw Hospital LLC | Camden, SC | $7.93M |
| Wilmington Physicians Group LLC | Wilmington, OH | $3.04M |
| Phc-Morgan City LP | Morgan City, LA | $2.37M |
| Community Hospital of Andalusia LLC | Andalusia, AL | $2.27M |
| Vaughan Regional Medical Center LLC | Marion, AL | $2.15M |
| PRHC Ennis LP | Ennis, TX | $1.81M |
| Andalusia Physician Practices LLC | Andalusia, AL | $847K |
| Meadowview Physician Practice LLC | Maysville, KY | $783K |
| Logan Physician Practice LLC | Auburn, KY | $458K |
| Logan Physician Practice LLC | Russellville, KY | $317K |
| Kentucky Mso LLC | Georgetown, KY | $248K |
| Rchp-Wilmington, LLC | Wilmington, OH | $165K |
| Meadowview Physician Practice LLC | Maysville, KY | $140K |
| Amg-Southern Tennessee LLC | Monteagle, TN | $136K |
| Lake Cumberland Physician Practices LLC | Somerset, KY | $135K |
| Lake Cumberland Physician Practices LLC | Somerset, KY | $57K |
| Kershaw Hospital LLC | Lugoff, SC | $49K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.